open navigation

Board of Directors

Return to Common Sensing

Kevin Schmid

Kevin Schmid

Board Vice-Chairman: Since November 2015, Kevin has served as a member of the Board of Directors for Common Sensing, Inc. Since January 2018, he has served as a member of the Board of Directors for Sorrel Medical Ltd. Sorrel Medial is an Israel based company that develops wearable, pre-filled cartridge-based drug delivery platform technology. Kevin earned a Bachelor of Science in Mechanical Engineering from Clarkson University and a Master of Business Administration from Sacred Heart University.

James White

James White

James is a co-founder of Common Sensing and currently serves on the board. James received his B.S. Engineering from MIT in 2010 and M.S. from MIT in 2012, where he worked on the software, electrical, and mechanical design and control of automatic ocular jet injectors in Ian Hunter’s Bioinstrumentation Lab. Having been instilled with a strong passion for improving lives through better medical devices, James and Rich invented Gocap around their kitchen table in January 2012. Outside of medical devices, James develops video games, leads mountaineering trips, and advises/invests in technology companies.

Richard Whalley

Richard Whalley

Richard is a creative technologist and healer focused on leading diverse teams to build life-changing products and experiences that serve people in need. He is an MIT engineer and before co-founding Common Sensing, he consulted for biotech startups to help them tell their stories to investors. Catch him outside of work and you may be able to find him drumming, playing soccer, or meditating.

Robbie Greenglass

Robbie Greenglass

Robbie is an investor at Waterline Ventures, which he founded in 2014, focusing on investments in healthcare technology. He has also spent time as the Vice President of Business Development at Shields Health Solutions, a hospital services company in the specialty pharmacy space. Prior to founding Waterline, Robbie was an investor at Highland Capital Partners, and helped launch Causeway Media Partners, a sports technology investment fund. Prior to Highland, he was an investment banker in the Healthcare Group at Oppenheimer & Co. and CIBC World Markets. Robbie received a B.A. from Brown University and a M.B.A. from Harvard Business School.

Patrick Flynn

Patrick Flynn

Patrick is an entrepreneur with more than 35 years of senior executive experience. He has provided leadership to numerous successful organizations including start-ups and Fortune 100 companies and has served in a variety of roles, including CEO, COO, CFO, and advisor. In addition to his role as an advisor and board member to Common Sensing, he currently serves as the COO of Good Measures, where he is responsible for the day-to-day operations of the company’s innovative healthcare and nutrition services. In 2018 Patrick joined the board of NeuroRx, which recently received an FDA “Breakthrough Therapy designation” for its drug, NRX-101, introducing a new class of antidepressants for bipolar suicidality, PTSD, and depression.

John Dwyer

John Dwyer

John first became a CEO at the age of 30. In the following years, he held “C” level positions in six emerging growth companies in the healthcare industry. He previously served as the co-founder and Chairman of Telcare, Inc. and CEO of e-Medex, Inc., which later merged with Active Health Management to become the leading provider of health information management services. John is President of the Global Alzheimer’s Platform Foundation, and co-founded Us Against Alzheimer’s. He is on the Board of Directors for various private and not-for-profit organizations and is a graduate of Marquette University and Cornell Law School.